Medexus Pharmaceuticals Inc. (TSX: MDP)

Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	45	32	67	131	49	60
Market Cap Growth	46.46%	-51.59%	-48.90%	166.14%	-17.66%	62.56%
Enterprise Value	105	110	128	167	95	53
PE Ratio	4.55	19.36	-16.96	-3.38	-8.16	-8.93
PS Ratio	0.28	0.22	0.64	1.20	0.68	1.72
PB Ratio	1.10	1.05	2.74	5.30	1.48	1.56
P/FCF Ratio	1.57	-13.09	-5.49	-16.71	-14.57	-18.41
P/OCF Ratio	2.15	-16.37	-41.37	18.97	-22.13	-22.48
EV/Sales Ratio	0.66	0.75	1.22	1.53	1.33	1.52
EV/EBITDA Ratio	4.11	5.54	-15.03	18.13	40.72	27.29
EV/EBIT Ratio	5.99	9.50	-7.57	165.82	-34.74	-74.37
EV/FCF Ratio	3.69	-44.65	-10.53	-21.29	-28.19	-16.29
Debt / Equity Ratio	1.77	3.12	3.08	2.49	1.60	0.61
Debt / EBITDA Ratio	2.81	4.81	-8.80	6.69	22.74	11.93
Debt / FCF Ratio	2.52	-38.81	-6.17	-7.85	-15.75	-7.12
Quick Ratio	0.46	0.42	0.51	0.94	0.59	2.77
Current Ratio	1.11	0.87	1.02	1.47	1.17	3.31
Asset Turnover	0.71	0.67	0.55	0.54	0.43	0.30
Interest Coverage	0.59	0.56	-1.23	-0.14	-0.84	-1.51
Return on Equity (ROE)	19.89%	5.44%	-16.18%	-156.87%	-18.11%	-17.53%
Return on Assets (ROA)	3.67%	0.76%	-2.07%	-19.03%	-3.58%	-5.75%
Return on Capital (ROIC)	15.51%	8.23%	-20.64%	-2.19%	-8.58%	-9.82%
Earnings Yield	18.06%	5.17%	-5.90%	-29.58%	-12.25%	-11.20%
FCF Yield	63.73%	-7.64%	-18.22%	-5.98%	-6.86%	-5.43%
Buyback Yield / Dilution	-20.68%	-3.36%	-30.65%	-5.83%	-44.92%	-74.38%
Total Shareholder Return	-20.68%	-3.36%	-30.65%	-5.83%	-44.92%	-74.38%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.